BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33230700)

  • 21. Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping.
    Song LW; Wang YB; Fang LL; Wu Y; Yang L; Chen JY; Ge SX; Zhang J; Xiong YZ; Deng XM; Min XP; Zhang J; Chen PJ; Yuan Q; Xia NS
    Anal Chem; 2015; 87(10):5173-80. PubMed ID: 25892477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations.
    Cruz HM; Scalioni Lde P; de Paula VS; da Silva EF; do Ó KM; Milagres FA; Cruz MS; Bastos FI; Pollo-Flores P; Leal E; Motta-Castro AR; Pilotto JH; Lewis-Ximenez LL; Lampe E; Villar LM
    BMC Infect Dis; 2015 Nov; 15():548. PubMed ID: 26619906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].
    Ohne K; Kani S; Ohashi M; Shinkai N; Inoue T; Wakimoto Y; Tanaka Y
    Rinsho Byori; 2013 Sep; 61(9):787-94. PubMed ID: 24369590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique.
    Aoki M; Saito T; Watanabe H; Matsuo T; Saito K; Togashi H; Kawata S; Ishikawa K; Aoyama M; Kamada H; Shinzawa H
    J Med Virol; 2002 Feb; 66(2):166-70. PubMed ID: 11782924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters.
    Martiskainen I; Juntunen E; Salminen T; Vuorenpää K; Bayoumy S; Vuorinen T; Khanna N; Pettersson K; Batra G; Talha SM
    Sensors (Basel); 2021 Jan; 21(2):. PubMed ID: 33418986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.
    Ismail N; Fish GE; Smith MB
    J Clin Microbiol; 2004 Feb; 42(2):610-7. PubMed ID: 14766824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay.
    Sato S; Ohhashi W; Ihara H; Sakaya S; Kato T; Ikeda H
    Transfusion; 2001 Sep; 41(9):1107-13. PubMed ID: 11552066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
    Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
    J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.
    Weber B; Dengler T; Berger A; Doerr HW; Rabenau H
    J Clin Microbiol; 2003 Jan; 41(1):135-43. PubMed ID: 12517838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple and rapid capillary chemiluminescence immunoassay for quantitatively detecting human serum HBsAg.
    Xiang A; Wei F; Lei X; Liu Y; Liu Y; Guo Y
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1557-64. PubMed ID: 23780696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab.
    Sato K; Ichiyama S; Iinuma Y; Nada T; Shimokata K; Nakashima N
    J Clin Microbiol; 1996 Jun; 34(6):1420-2. PubMed ID: 8735091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
    Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
    J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
    Jongerius JM; Wester M; Cuypers HT; van Oostendorp WR; Lelie PN; van der Poel CL; van Leeuwen EF
    Transfusion; 1998 Jan; 38(1):56-9. PubMed ID: 9482395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.
    Minekawa T; Takehara S; Takahashi M; Okamoto H
    Clin Vaccine Immunol; 2013 Aug; 20(8):1255-65. PubMed ID: 23761660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upconverting nanoparticle clustering based rapid quantitative detection of tetrahydrocannabinol (THC) on lateral-flow immunoassay.
    Chand R; Mittal N; Srinivasan S; Rajabzadeh AR
    Analyst; 2021 Jan; 146(2):574-580. PubMed ID: 33174869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
    Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
    Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.